Lansoprazol Cinfamed (Lansoprazole)

Lansoprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme, also known as the gastric proton pump, located on the secretory surface of parietal cells. This inhibition blocks the final step of acid production, leading to a sustained reduction in gastric acid output and an increase in gastric pH, which supports symptom relief and mucosal healing.

The appropriate dose of Lansoprazol Cinfamed is determined by the prescribing healthcare professional based on the specific indication, severity of the condition, patient age, renal function, and any concomitant therapies. Dosage recommendations are provided in the product labeling, and the prescriber will tailor the regimen to each individual patient.

Safety data for lansoprazole in pregnancy and lactation are limited. The product is classified as pregnancy category unknown, and the decision to use it during pregnancy or while breastfeeding should be made by a qualified healthcare provider after weighing potential benefits against possible risks to the mother and fetus or infant.

To order Lansoprazol Cinfamed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the enquiry, the sales team will request trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lansoprazol Cinfamed is one of several proton pump inhibitors (PPIs) that share a common mechanism of reducing gastric acid secretion. Compared with other PPIs, lansoprazole has a similar efficacy profile but may differ in pharmacokinetic properties such as onset of action, metabolism pathways, and potential drug‑interaction profiles. Choice of a specific PPI often depends on clinician preference, patient tolerance, and individual drug‑interaction considerations.

Lansoprazol Cinfamed should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in areas with excessive heat or humidity, and keep it out of reach of children.

Lansoprazol Cinfamed is administered orally, typically as a tablet or capsule taken with water. The medication is usually taken before a meal, often in the morning, but the exact timing and frequency should follow the prescribing clinician’s instructions. Swallow the dosage form whole; do not crush or chew unless specifically advised.

Serious risks, although rare, include Clostridioides difficile‑associated diarrhea, acute interstitial nephritis, and severe hypomagnesemia, which can lead to muscle cramps, seizures, or cardiac arrhythmias. Patients should be monitored for persistent diarrhea, unexplained rash or fever, and signs of low magnesium, especially during prolonged therapy.

Lansoprazol Cinfamed should be avoided in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of osteoporosis when long‑term use is considered.